(S)-8-Chloro-2-(1-((2,6-diamino-5-chloropyrimidin-4-yl)-amino)ethyl)-6-fluoro-3-(1H-pyrazol-3-yl)quinazolin-4(3H)-one

ID: ALA4082978

Cas Number: 1842380-77-1

PubChem CID: 118575663

Max Phase: Preclinical

Molecular Formula: C17H14Cl2FN9O

Molecular Weight: 450.26

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](Nc1nc(N)nc(N)c1Cl)c1nc2c(Cl)cc(F)cc2c(=O)n1-c1cc[nH]n1

Standard InChI:  InChI=1S/C17H14Cl2FN9O/c1-6(24-14-11(19)13(21)26-17(22)27-14)15-25-12-8(4-7(20)5-9(12)18)16(30)29(15)10-2-3-23-28-10/h2-6H,1H3,(H,23,28)(H5,21,22,24,26,27)/t6-/m0/s1

Standard InChI Key:  SAWISWWSHNTVLW-LURJTMIESA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   22.6406  -10.7927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6394  -11.6122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3475  -12.0212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3457  -10.3838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0543  -10.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0531  -11.6143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7632  -12.0256    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.4790  -11.6163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4802  -10.7911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7656  -10.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7656   -9.5580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1856  -12.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1833  -12.8441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.8944  -11.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8898  -13.2547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2994  -14.0746    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2991  -13.2532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5928  -12.8464    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5896  -14.4813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8863  -14.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1872  -10.3868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5874  -15.2985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.9270  -10.7166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4744  -10.1136    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0701   -9.4066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2728   -9.5727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1774  -14.4799    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   29.0065  -12.8441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3472  -12.8384    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   21.9328  -10.3842    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
  8 12  1  0
 12 13  1  6
 12 14  1  0
 13 15  1  0
 15 20  2  0
 19 16  2  0
 16 17  1  0
 17 18  2  0
 18 15  1  0
 19 20  1  0
  9 21  1  0
 19 22  1  0
 21 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 20 27  1  0
 17 28  1  0
  3 29  1  0
  1 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4082978

    PI3K-IN-6

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3R1 Tchem PI3-kinase p110-alpha/p85-alpha (2589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3R1 Tchem PI3K p110 beta/p85 alpha (919 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3R1 Tchem PI3-kinase p110-delta/p85-alpha (1508 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CG Tclin PI3-kinase p110-gamma subunit (5411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-415 (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ZR-75-1 (953 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cynomolgus monkey (4946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.26Molecular Weight (Monoisotopic): 449.0682AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 153.42Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.14CX Basic pKa: 6.16CX LogP: 2.91CX LogD: 2.90
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.37Np Likeness Score: -1.52

References

1. Perreault S, Chandrasekhar J, Cui ZH, Evarts J, Hao J, Kaplan JA, Kashishian A, Keegan KS, Kenney T, Koditek D, Lad L, Lepist EI, McGrath ME, Patel L, Phillips B, Therrien J, Treiberg J, Yahiaoui A, Phillips G..  (2017)  Discovery of a Phosphoinositide 3-Kinase (PI3K) β/δ Inhibitor for the Treatment of Phosphatase and Tensin Homolog (PTEN) Deficient Tumors: Building PI3Kβ Potency in a PI3Kδ-Selective Template by Targeting Nonconserved Asp856.,  60  (4): [PMID:28106991] [10.1021/acs.jmedchem.6b01821]

Source